导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.85% | 1449/2953 |
| 近一周 | 0.03% | 822/3213 |
| 近一月 | -0.10% | 1554/3217 |
| 近一季 | 0.35% | 1264/3188 |
| 近半年 | 0.33% | 1242/3108 |
| 近一年 | 1.08% | 1379/2916 |
| 近两年 | 5.30% | 1653/2411 |
| 近三年 | 9.35% | 1231/2049 |
| 成立以来 | 34.68% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-0.18% 1376/3040 |
0.77% 2206/3451 |
-0.24% 1520/3497 |
- - |
| 2024 | 3.92% 2016/3316 |
1.09% 1846/3226 |
1.11% 1831/3360 |
0.23% 1817/3195 |
1.44% 2261/3316 |
| 2023 | 3.74% 1117/3108 |
1.01% 1045/2776 |
1.27% 1061/2849 |
0.51% 1351/2940 |
0.90% 1385/3108 |
| 2022 | 2.27% 1237/2727 |
0.53% 950/1949 |
0.93% 1099/2522 |
1.33% 479/2598 |
-0.54% 1726/2732 |
| 2021 | 4.23% 890/2409 |
0.80% 716/2068 |
0.95% 1357/2668 |
1.33% 776/2731 |
1.09% 1109/2416 |
| 2020 | 2.96% 656/2196 |
2.16% 592/1576 |
0.04% 562/2274 |
0.02% 1003/2475 |
0.73% 1667/2563 |
| 2019 | 5.26% 241/1720 |
1.37% 744/1682 |
1.17% 122/1824 |
1.50% 342/1762 |
1.11% 641/1956 |
| 2018 | 7.68% 204/1267 |
- - |
- - |
- - |
1.71% 536/1543 |
| 2017 | -0.07% 641/1017 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 招商招顺纯债A VS. () |